Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIDEA.L Regulatory News (IDEA)

  • There is currently no data for IDEA

Board Appointment

4 Sep 2017 07:00

RNS Number : 6139P
Ideagen PLC
04 September 2017
 

4 September 2017

Ideagen plc

 

("Ideagen" or the "Company")

 

Board Appointment

Ideagen PLC (AIM: IDEA), a leading supplier of Information Management Software to highly regulated industries, is pleased to announce the appointment of Tony Rodriguez to its board of directors as a non-executive director with immediate effect.

Mr Rodriguez, aged 48, is an experienced technology entrepreneur and software developer. After an early career in a number of blue-chip technology companies, he founded Avellino Technologies Ltd in 1997, and personally led the development of its data profiling software product, now known as TS Discovery, before its acquisition in 2004 by Harte Hanks Trillium. Subsequently he founded X88 Software, since acquired by Experian in 2014, where he led, as CEO and CTO, the development of its data management product (now known as Experian Pandora), which was recognised as a visionary by Gartner.

Jonathan Wearing, Chairman, commented that:

"We are delighted that Tony has agreed to join the Board. He brings to Ideagen a wealth of experience in successfully developing and commercialising market-leading software, which will be extremely helpful as we continue to drive forward the growth of the business."

Further information, as required pursuant to Schedule 2(g) of the AIM Rules for Companies, are set out below.

Current directorships and/or partnerships:

Former directorships and/or partnerships (within the last five years):

X88 Limited

X88 Software Limited

Tony Rodriguez Limited

There are no further disclosures required under Schedule 2(g) of the AIM Rules for Companies.

The information communicated in this announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No. 596/2014.

 

Enquiries:

Ideagen plc

Tel: 01629 699100

David Hornsby, Chief Executive

Graeme Spenceley, Finance Director

finnCap (Nominated Adviser and Broker)

Tel: 020 7220 0500

Stuart Andrews / James Thompson (Corporate Finance)

Stephen Norcross (Corporate Broking)

 

About Ideagen plc

Ideagen is a UK company quoted on the London Stock Exchange AIM market (Ticker: IDEA.L).

Ideagen is a supplier of Information Management software with operations in the UK, the United States and the Middle East. The Company specialises in GRC (Governance, Risk and Compliance) and Content and Clinical solutions with a primary focus on organisations operating within highly regulated industries. With an excellent portfolio of software products, Ideagen is able to provide complete information lifecycle solutions that enable organisations to reduce risk, meet their regulatory and compliance standards, helping them to reduce costs and improve efficiency.

The Group has a customer base of over 3,000 organisations using the Ideagen suite of products, including many blue chip names such as BAE Systems, Emirates, Shell and the European Central Bank as well as 150 hospitals in the UK and US.

For further information please visit www.ideagen.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAUGUQGBUPMGPG
Date   Source Headline
26th Jan 201610:43 amRNSDirector/PDMR Shareholding
26th Jan 20167:00 amRNSInterim Results
13th Jan 20161:41 pmRNSHolding(s) in Company
22nd Dec 20157:00 amRNSExercise of Options and Total Voting Rights
11th Dec 20159:53 amRNSHolding(s) in Company
25th Nov 20151:42 pmRNSHolding(s) in Company
24th Nov 20157:00 amRNSHolding(s) in Company
19th Nov 20157:00 amRNSTrading Update
5th Nov 201511:23 amRNSChange of Registered Office Address
29th Oct 20153:59 pmRNSResult of AGM
20th Oct 20157:00 amRNSExercise of Options
7th Oct 20157:00 amRNSNotice of AGM
23rd Sep 20158:15 amRNSEnlighten product wins GRC Innovation Award
3rd Sep 20157:00 amRNSNew Contract Extensions worth £1m
10th Aug 20157:00 amRNSExercise of Options and Total Voting Rights
31st Jul 201511:54 amRNSDirector Dealing
23rd Jul 20157:00 amRNSGrant of Share Options
22nd Jul 20157:00 amRNSFinal Results
9th Jul 20157:00 amRNSNotice of Results
30th Jun 20159:19 amRNSShares Magazine Investor Event
3rd Jun 201511:25 amRNSHolding(s) in Company
21st May 20157:00 amRNSG-Cloud Award and New Contract Win
14th May 20157:00 amRNSPre-Close Trading Update
7th May 20157:00 amRNSExercise of Options and Total Voting Rights
30th Apr 201510:26 amRNSHolding(s) in Company
23rd Apr 201511:55 amRNSHolding(s) in Company
20th Apr 20152:53 pmRNSReplacement Director Dealing & Total Voting Rights
20th Apr 20157:00 amRNSDirector Dealing & Total Voting Rights
15th Apr 201511:25 amRNSHolding(s) in Company
11th Mar 201511:23 amRNSHolding(s) in Company
6th Mar 201512:57 pmRNSHolding(s) in Company
25th Feb 20157:00 amRNSExercise of Options and Total Voting Rights
24th Feb 20157:00 amRNSNew Aviation Contract Wins worth £1m
29th Jan 20157:00 amRNSInterim Results
20th Jan 20153:41 pmRNSHolding(s) in Company
16th Jan 201512:44 pmRNSHolding(s) in Company
16th Jan 201512:42 pmRNSHolding(s) in Company
13th Jan 20151:04 pmRNSCompletion of Acquisition of Gael Limited
9th Jan 201511:55 amRNSHolding(s) in Company
7th Jan 201512:56 pmRNSResult of General Meeting
18th Dec 20147:00 amRNSAcquisition, Placing and Notice of General Meeting
13th Nov 20147:00 amRNSTrading update and Notice of Results
5th Nov 20148:30 amRNSIdeagen selected by NuGen
31st Oct 20141:47 pmRNSResult of AGM
9th Oct 20147:00 amRNSNotice of 2014 Annual General Meeting ("AGM")
2nd Oct 20147:00 amRNSContract Win and Trading Update
4th Aug 20147:00 amRNSIssue of Equity
22nd Jul 20147:00 amRNSFinal Results
10th Jul 20147:00 amRNSNotice of Results
25th Jun 20147:01 amRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.